- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 222.32M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 202.06M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $92.57M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $2.64M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $497K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $11.4M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.44M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $128.82M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $192.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $483.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.03B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.79B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.86B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $2.37B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $2.3B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $18.6B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $19.49B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $21.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $22.35B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.20 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.22 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.20 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.22 |
| Net Income | Q1 2026 · Mar 31, 2026 | $44.09M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $43.79M |
| Revenue | Q1 2026 · Mar 31, 2026 | $13.02M |
| Revenue | Q1 2026 · Mar 31, 2025 | $11.5M |